IRIS
SOLLA, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.563
AS - Asia 3.317
SA - Sud America 2.853
EU - Europa 999
AF - Africa 168
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 8
Totale 12.922
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.409
BR - Brasile 2.515
SG - Singapore 1.657
CN - Cina 507
VN - Vietnam 326
HK - Hong Kong 307
IT - Italia 195
DE - Germania 187
AR - Argentina 136
UA - Ucraina 123
FI - Finlandia 103
GB - Regno Unito 75
RU - Federazione Russa 71
CA - Canada 70
BD - Bangladesh 58
TR - Turchia 58
EC - Ecuador 56
ZA - Sudafrica 53
MX - Messico 52
IN - India 49
IQ - Iraq 47
ID - Indonesia 44
FR - Francia 38
MA - Marocco 37
UZ - Uzbekistan 36
VE - Venezuela 33
CO - Colombia 30
PK - Pakistan 30
ES - Italia 24
NL - Olanda 24
PY - Paraguay 24
AT - Austria 23
PE - Perù 23
AE - Emirati Arabi Uniti 22
JP - Giappone 22
PL - Polonia 20
TN - Tunisia 20
AZ - Azerbaigian 18
CZ - Repubblica Ceca 18
SE - Svezia 18
KE - Kenya 16
NP - Nepal 15
EG - Egitto 14
JO - Giordania 14
TH - Thailandia 14
UY - Uruguay 13
BE - Belgio 12
CL - Cile 12
LT - Lituania 11
MY - Malesia 11
PH - Filippine 11
EU - Europa 9
OM - Oman 9
AU - Australia 8
BO - Bolivia 8
CR - Costa Rica 8
DZ - Algeria 8
GR - Grecia 7
AL - Albania 6
IL - Israele 6
JM - Giamaica 6
KR - Corea 6
RS - Serbia 6
IE - Irlanda 5
KG - Kirghizistan 5
KZ - Kazakistan 5
LB - Libano 5
PS - Palestinian Territory 5
RO - Romania 5
SA - Arabia Saudita 5
SN - Senegal 5
AO - Angola 4
BG - Bulgaria 4
BN - Brunei Darussalam 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
GE - Georgia 4
HN - Honduras 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
CI - Costa d'Avorio 3
GT - Guatemala 3
HU - Ungheria 3
LU - Lussemburgo 3
PA - Panama 3
AM - Armenia 2
DK - Danimarca 2
EE - Estonia 2
GY - Guiana 2
IR - Iran 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MN - Mongolia 2
NG - Nigeria 2
QA - Qatar 2
TJ - Tagikistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
BF - Burkina Faso 1
Totale 12.905
Salva come PNG Salva come JPEG
Città #
Dallas 3.063
Singapore 830
Chandler 513
Hong Kong 303
Princeton 222
Ashburn 193
Beijing 172
São Paulo 156
Ho Chi Minh City 119
Shanghai 105
Rio de Janeiro 82
Los Angeles 81
Helsinki 80
Belo Horizonte 72
Hanoi 70
New York 63
Munich 55
Santa Clara 55
Brasília 52
Wilmington 46
Jacksonville 37
The Dalles 36
Campinas 35
Johannesburg 34
Porto Alegre 34
Tashkent 33
Columbus 31
Curitiba 27
Cagliari 26
Guarulhos 25
Nuremberg 24
Quito 24
Salvador 24
Buenos Aires 23
Montreal 23
Toronto 23
Brooklyn 22
Denver 22
Falls Church 22
Jakarta 22
Rome 22
Haiphong 21
Tokyo 21
Baghdad 19
Frankfurt am Main 19
Warsaw 19
Lima 18
London 18
Mexico City 18
Atlanta 17
Campo Grande 17
Düsseldorf 17
Recife 17
Baku 16
Fortaleza 16
Franca 16
Juiz de Fora 16
Orem 16
San Francisco 16
Contagem 15
Manaus 15
Ribeirão Preto 15
Turku 15
Amman 14
Amsterdam 14
Asunción 14
Chennai 14
Council Bluffs 14
Guayaquil 14
Poplar 14
Santo André 14
Sorocaba 14
Bangkok 13
Betim 13
Dhaka 13
Falkenstein 13
São José do Rio Preto 13
Uberlândia 13
Brussels 12
Florianópolis 12
Guangzhou 12
Limeira 12
Mauá 12
Nairobi 12
Osasco 12
Stockholm 12
Ankara 11
Boston 11
Cape Town 11
Casablanca 11
Goiânia 11
Istanbul 11
Joinville 11
Sassari 11
Taubaté 11
Várzea Paulista 11
Bauru 10
Campos dos Goytacazes 10
Cotia 10
Da Nang 10
Totale 7.728
Salva come PNG Salva come JPEG
Nome #
The role of 123I-MIBG cardiac scintigraphy in the patients with movement disorders (MD). 317
Teaching Video NeuroImage: The "Chameleon Eyes Sign" in Myasthenia Gravis 178
Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice 178
123I-Ioflupane brain SPECT (I-SPECT) and brain parenchyma sonography (BPS) combined use in movement disorder diagnosis 157
Herv-k modulates the immune response in als patients 154
The natural history of body-first versus brain-first Parkinson's disease subtypes 147
Adapted physical activity on motor and non-motor symptoms, and quality of life in Parkinson's disease patients 141
Body weight-supported high-intensity locomotor training and adapted physical activity program in patients with Parkinson's disease: a complementary approach? 139
Diagnostic Value of the "Insular Knife-Cut" Sign in Patients With Suspected Herpes Simplex Virus Encephalitis 132
An Ancient Tradition, A New Kind Of Physical Activity: The Sardinian Folk Dance ‘Ballu Sardu’ 132
18F-FDG PET/CT in patients with autoimmune encephalitis in the early stage. 131
Early discontinuation and titration strategies in foslevodopa/foscarbidopa therapy for Parkinson's disease 130
Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis 130
Bipolar affective disorder and Parkinson's disease: A rare, insidious and often unrecognized association 128
Navigating the Neuropsychiatric Risks of Foslevodopa/Foscarbidopa in Patients with Parkinson's Disease 126
A new type of physical activity from an ancient tradition: the Sardinian folk dance "ballu sardu" 123
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study 121
Behavioral, neuropsychiatric and cognitive disorders in Parkinson's disease patients with and without motor complications 121
Clinical Significance of Myelin Oligodendrocyte Glycoprotein Autoantibodies in Patients with Typical MS Lesions on MRI 121
An unusual delusion of duplication in a patient affected by Dementia with Lewy bodies 120
Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa-Carbidopa Intestinal Gel: A Nation-Wide, Multicenter, Longitudinal, "Real-World" Study. The EPIC Study 120
Alternating or metronome pisa syndrome in patients under drugs acting on dopaminergic pathways 118
Author Response: Teaching Video NeuroImage: Bilateral Hemifacial Spasm in Giant Cell Arteritis 117
Aberrant sexual behaviours in Parkinson's disease during dopaminergic treatment [2] 117
18F-FDG Brain PET/CT Metabolic Imaging in Patients with Suspected Autoimmune Encephalitis (AE) in the Early Stage: Can the Procedure Play a Complementary Diagnostic Role? 117
C9ORF72 Intermediate Repeat Expansion in a Patient with Psychiatric Disorders and Progressive Cerebellar Ataxia 114
Drosophila mutant model of Parkinson's disease revealed an unexpected olfactory performance: Morphofunctional evidences 112
[123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism 111
Functional and morphological correlates in the drosophila LRRK2 loss-of-function model of Parkinson's disease: Drug effects of withania somnifera (Dunal) administration 109
Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis Patients 108
Exposure to TNF inhibitors is rare at MOGAD presentation 104
Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up study 102
Autoimmune encephalitis misdiagnosis and mimics 95
Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD 94
Association between fatigue and other motor and non-motor symptoms in Parkinson's disease patients 93
Metabolomics as a Tool for the characterization of Drug-resistant epilepsy 91
Association between olfactory dysfunction and motor subtypes in Parkinson’s disease: are non-tremor-dominant subtypes really uncorrelated to olfactory impairment? 90
VGF peptides as novel biomarkers in Parkinson’s disease 89
Tdp‐43 and herv‐k envelope‐specific immunogenic epitopes are recognized in als patients 89
The TANDEM investigation: efficacy and tolerability of levodopa-carbidopa intestinal gel in (LCIG) advanced Parkinson’s disease patients 89
Different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 89
Fluctuating off-period hemidystonia with Pisa syndrome in advanced Parkinson's disease 88
Pisa syndrome in a patient with pathologically confirmed Parkinson's disease 88
Beneficial Effect of Phenytoin and Carbamazepine on GFAP Gene Expression and Mutant GFAP Folding in a Cellular Model of Alexander’s Disease 88
Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination 87
Cerebellar continuous theta burst stimulation reduces levodopa-induced dyskinesias and decreases serum BDNF levels 87
The p.A382T TARDBP gene mutation in Sardinian patients affected by Parkinson's disease and other degenerative parkinsonisms 86
Teaching Video NeuroImage: Bilateral Hemifacial Spasm in Giant Cell Arteritis 85
Neurological and Psychiatric Disorders in the COVID-19 Era 84
Sardinian Folk Dance for Individuals with Parkinson's Disease: A Randomized Controlled Pilot Trial 84
Effects of a nordic walking program on motor and non-motor symptoms, functional performance and body composition in patients with Parkinson's disease 84
Description (reporting the actual words used in written letters) of the neuropsychological and psychopathological modifications produced by dopaminergic treatment in a young patient with Parkinson's disease 83
A top-down proteomic approach reveals a salivary protein profile able to classify Parkinson's disease with respect to Alzheimer's disease patients and to healthy controls 82
Pisa-like syndrome under Baclofen in a patient with spastic hemiparesis due to ischemic stroke 82
Prolonged B-cell depletion after rituximab in AQP4-IgG-positive neuromyelitis optica spectrum disorder 82
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study 80
Effects of an adapted physical training on functional status, body composition and quality of life in persons with spinal cord injury paraplegia: a pilot study 79
Effect of olfactory and gustatory dysfunction and motor symptoms on body weight in patients with parkinson’s disease 79
Capgras syndrome in Parkinson’s disease: two new cases and literature review 79
Epilepsy and sexual funtcion in male and female subjects treated with old and new AEDs, on poly or monotherapy: Preliminary data 78
Delusional jealousy in Parkinson's disease patients with and without dementia 78
A new national survey of centers for cognitive disorders and dementias in Italy 77
Paraphilias and paraphilic disorders in Parkinson's disease: A systematic review of the literature 77
Effects of a mini-trampoline rebounding exercise program on functional parameters, body composition and quality of life in overweight women 77
Nonconvulsive status epilepticus as onset of Creutzfeldt-Jakob disease 77
C9ORF72 intermediate repeat expansion in patients affected by atypical Parkinsonian syndromes or parkinson’s disease complicated by psychosis or dementia in a Sardinian population 77
Epidemiology of aquaporin-4-IgG-positive NMOSD in Sardinia 77
Immune responses to oligomeric α-synuclein in Parkinson's disease peripheral blood mononuclear cells 76
Study on the correlation among total burden of nonmotor symptoms and cardiovascular dysmodulation in Parkinson’s disease patients 76
Clozapine-induced persistent hiccup in a patient with Alzheimer's disease 76
Seasonal variation in myasthenia gravis incidence 76
Epidemiology of seropositive myasthenia gravis in Sardinia: A population-based study in the district of Sassari 75
Suicide and dopamine agonist withdrawal syndrome in Parkinson's disease 75
Diphasic dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion in Parkinson's disease 75
Heart rate variability shows different cardiovascular modulation in Parkinson’s disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 75
Olfactory Impairment Is the Main Predictor of Higher Scores at REM Sleep Behavior Disorder (RBD) Screening Questionnaire in Parkinson’s Disease Patients 74
Correlation among olfactory function, motors’ symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson’s disease 74
Land- and water-based sports activities in natural environments as a group exercise for Parkinson’s disease: proof-of-concept pilot study 74
Olfactory hallucinations in Parkinson's disease patients and the role of their evaluation in clinical practice 73
Internal carotid artery dissection causing ischemic stroke during pole sport practice 73
Nordic Walking for the Management of People With Parkinson Disease: A Systematic Review 73
Non-demyelinating disorders mimicking and misdiagnosed as NMOSD: a literature review 72
Frequency and determinants of olfactory hallucinations in parkinson’s disease patients 72
Dopamine agonist withdrawal syndrome in Parkinson's disease 71
Relationship between risk and protective factors and clinical features of Parkinson's disease 71
Neuroimaging evaluations of olfactory, gustatory, and neurological deficits in patients with long-term sequelae of COVID-19 71
Current Advancement of Immunomodulatory Drugs as Potential Pharmacotherapies for Autoimmunity Based Neurological Diseases 70
Effects of an adapted physical activity program on motor and non-motor functions and quality of life in patients with Parkinson's disease 70
Sex-related differences in olfactory function and evaluation of possible confounding factors among patients with Parkinson’s disease 70
Corrigendum to [123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism [Schizophr. Res. 113 (2009) 41-48] 70
The imbalance of serotonergic circuitry impairing the crop supercontractile muscle activity and the mitochondrial morphology of PD PINK1B9 Drosophila melanogaster are rescued by Mucuna pruriens 70
Hypersexual behaviour, frotteurism and delusional jealousy in a young parkinsonian patient during dopaminergic therapy with pergolide: A rare case of iatrogenic paraphilia 70
Treatment of benign essential blepharospasm with finasteride: A case report 70
Risk factors of Parkinson disease Simultaneous assessment, interactions, and etiologic subtypes 69
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD 69
Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion 68
Chronic inflammatory demyelinating polyneuropathy after chadox1 ncov-19 vaccination 68
Phantosmia in Parkinson’s Disease: A Systematic Review of the Phenomenology of Olfactory Hallucinations 67
Olfactory Impairment in Parkinson’s Disease Patients with Tremor Dominant Subtype Compared to Those with Akinetic Rigid Dominant Subtype: A Pilot Study 67
Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study 66
Totale 9.585
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.420
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.420
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021132 0 0 0 0 0 0 16 0 25 88 0 3
2021/2022434 14 2 0 10 11 14 6 27 18 22 99 211
2022/20231.000 120 74 58 149 76 173 3 99 171 13 40 24
2023/2024335 55 28 7 6 47 5 6 38 4 3 40 96
2024/20254.727 76 59 279 99 155 137 227 985 1.726 668 186 130
2025/20266.380 250 1.728 2.012 1.438 883 69 0 0 0 0 0 0
Totale 13.137